{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:57:55Z","timestamp":1761101875130},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/gme.0b013e3181b63c4d","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T08:17:35Z","timestamp":1262679455000},"page":"114-120","source":"Crossref","is-referenced-by-count":4,"title":["Submaximal exercise coronary artery flow increases in postmenopausal women without coronary artery disease after estrogen and atorvastatin"],"prefix":"10.1097","volume":"17","author":[{"given":"Chirapa","family":"Puntawangkoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Gregory","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210227","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R2-21-20210227","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","article-title":"Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen\/Progestin Replacement Study (HERS).","volume":"105","author":"Herrington","year":"2002","journal-title":"Circulation"},{"key":"R3-21-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R4-21-20210227","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ahj.2006.11.006","article-title":"Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.","volume":"153","author":"Yeboah","year":"2007","journal-title":"Am Heart J"},{"key":"R5-21-20210227","first-page":"1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause erratum in JAMA. 2008;299(12):1426.","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"R6-21-20210227","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"WHI and WHI-CACS Investigators. Estrogen therapy and coronary-artery calcification.","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"R7-21-20210227","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/hq1201.100241","article-title":"3rd, et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women.","volume":"21","author":"Herrington","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R8-21-20210227","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.ATV.0000115383.49802.0c","article-title":"Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.","volume":"24","author":"Wakatsuki","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R9-21-20210227","first-page":"209","article-title":"Statin therapy in the heart and estrogen\/progestin replacement study.","volume":"55","author":"Daniel","year":"2003","journal-title":"Minerva Ginecol"},{"key":"R10-21-20210227","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00004728-200605000-00012","article-title":"Cardiovascular magnetic resonance measurement of coronary arterial blood flow at rest and after submaximal exercise.","volume":"30","author":"Dall'Armellina","year":"2006","journal-title":"J Comput Assist Tomogr"},{"key":"R11-21-20210227","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1161\/01.CIR.93.8.1502","article-title":"Assessment of coronary arterial flow and flow reserve in humans with magnetic resonance imaging.","volume":"93","author":"Hundley","year":"1996","journal-title":"Circulation"},{"key":"R12-21-20210227","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.CIR.91.5.1347","article-title":"Noninvasive determination of infarct artery patency by cine magnetic resonance angiography.","volume":"91","author":"Hundley","year":"1995","journal-title":"Circulation"},{"key":"R13-21-20210227","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1161\/01.CIR.99.25.3248","article-title":"Visualization and functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging.","volume":"99","author":"Hundley","year":"1999","journal-title":"Circulation"},{"key":"R14-21-20210227","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).","volume":"344","author":"Pedersen","year":"1994","journal-title":"Lancet"},{"key":"R15-21-20210227","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"R16-21-20210227","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"CARDS Investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"R17-21-20210227","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"R18-21-20210227","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","article-title":"REVERSAL Investigators. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.","volume":"291","author":"Nissen","year":"2004","journal-title":"JAMA"},{"key":"R19-21-20210227","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.0000034508.55617.65","article-title":"ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.","volume":"106","author":"Taylor","year":"2002","journal-title":"Circulation"},{"key":"R20-21-20210227","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0021-9150(97)00252-9","article-title":"Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.","volume":"137","author":"Simons","year":"1998","journal-title":"Atherosclerosis"},{"key":"R21-21-20210227","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00005344-200011000-00011","article-title":"Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women.","volume":"36","author":"Marchesi","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"R22-21-20210227","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.ATV.20.1.61","article-title":"Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.","volume":"20","author":"Wagner","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R23-21-20210227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.103.1.113","article-title":"Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.","volume":"103","author":"Feron","year":"2001","journal-title":"Circulation"},{"key":"R24-21-20210227","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/hc1202.105945","article-title":"Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.","volume":"105","author":"Wakatsuki","year":"2002","journal-title":"Circulation"},{"key":"R25-21-20210227","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ahj.2005.09.005","article-title":"Women's Health Initiative Research Group. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.","volume":"152","author":"Hsia","year":"2006","journal-title":"Am Heart J"},{"key":"R26-21-20210227","first-page":"1095","article-title":"Antioxidant potential of specific estrogens on lipid peroxidation.","volume":"77","author":"Subbiah","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-21-20210227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R28-21-20210227","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/ATVBAHA.108.172718","article-title":"Is LDL-C passed its prime?: the emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.","volume":"28","author":"Davidson","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-21-20210227","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/ATVBAHA.108.170431","article-title":"Women's Health Initiative Research Group. Lipoprotein particle concentration may explain the absence of coronary protection in the Women's Health Initiative hormone trials.","volume":"28","author":"Hsia","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-201017010-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:32:22Z","timestamp":1618277542000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201017010-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181b63c4d","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}